Bioceres Crop Solutions (NASDAQ:BIOX) Issues Quarterly Earnings Results

Bioceres Crop Solutions (NASDAQ:BIOX) issued its quarterly earnings data on Tuesday, September 15th. The company reported ($0.39) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.33), reports. The company had revenue of $55.90 million for the quarter, compared to the consensus estimate of $79.00 million. Bioceres Crop Solutions had a negative return on equity of 39.11% and a negative net margin of 94.76%.

Here are the key takeaways from Bioceres Crop Solutions’ conference call:

• Fiscal 2026 revenue declined 18% to $238 million, while reported gross profit fell 21% to $82.9 million, reflecting the seed-business reconfiguration and weaker Crop Protection and inoculant sales.
• Fourth-quarter revenue was broadly stable year over year at $55.9 million, led by 36% growth in Crop Nutrition, while cost reductions helped adjusted EBITDA improve to positive $0.6 million from negative $9.6 million a year earlier.
• Management said the company is entering fiscal 2027 with a leaner cost structure and is targeting approximately 40% gross margins, supported by a simplified portfolio focused on higher-value products and core markets such as Brazil.
• Liquidity and capital structure remain significant risks, with $213.6 million of net financial debt and $118.6 million of secured notes classified as short term amid ongoing litigation over note acceleration and foreclosure.

Bioceres Crop Solutions Trading Up 0.9%

Shares of NASDAQ:BIOX traded up $0.00 during trading on Friday, reaching $0.37. 73,177 shares of the company were exchanged, compared to its average volume of 563,729. The business’s fifty day simple moving average is $0.39 and its 200-day simple moving average is $0.43. The company has a debt-to-equity ratio of 0.94, a current ratio of 0.81 and a quick ratio of 0.63. Bioceres Crop Solutions has a 12-month low of $0.30 and a 12-month high of $2.19. The firm has a market capitalization of $23.89 million, a PE ratio of -0.10 and a beta of 0.44.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings lowered shares of Bioceres Crop Solutions from a “sell (d)” rating to a “sell (d-)” rating in a research note on Monday, July 13th. Two research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and an average price target of $2.00.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing technologies that improve crop productivity, resilience and sustainability. The company’s offerings are designed to help farmers manage environmental stresses, enhance nutrient use and support more efficient crop production.

Bioceres’ portfolio includes genetically improved seed technologies, microbial inoculants, biological crop nutrition products, crop protection solutions and digital farming tools.